Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

156 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pneumocystis jirovecii pneumonia in patients with decompensated cirrhosis: a case series.
Franceschini E, Dolci G, Santoro A, Meschiari M, Riccò A, Menozzi M, Burastero GJ, Cuffari B, De Maria N, Serio L, Biagioni E, Catellani B, Sandro SD, Colecchia A, Girardis M, Benedetto FD, Mussini C. Franceschini E, et al. Among authors: ricco a. Int J Infect Dis. 2023 Mar;128:254-256. doi: 10.1016/j.ijid.2022.12.027. Epub 2023 Jan 4. Int J Infect Dis. 2023. PMID: 36610658 Free article.
Frailty and post-operative delirium influence on functional status in patients with hip fracture: the GIOG 2.0 study.
Gandossi CM, Zambon A, Ferrara MC, Tassistro E, Castoldi G, Colombo F, Mussi C, Martini E, Sergi G, Coin A, Zatti G, Trevisan C, Volpato S, Ungar A, Bellelli G; GIOG 2.0 Study Group, Società Italiana di Gerontologia e Geriatria (SIGG). Gandossi CM, et al. Aging Clin Exp Res. 2023 Nov;35(11):2499-2506. doi: 10.1007/s40520-023-02522-8. Epub 2023 Aug 5. Aging Clin Exp Res. 2023. PMID: 37542601 Free PMC article.
IRF4 dysregulation in chronic myelomonocytic leukemia: another brick in the wall of myelodysplastic/myeloproliferative neoplasms.
Tarantini F, Cumbo C, Parciante E, Anelli L, Zagaria A, Coccaro N, Tota G, Redavid I, Conserva MR, Minervini A, Minervini CF, Cellamare A, Casieri P, Nuzzi MC, Ricco A, Specchia G, Musto P, Albano F. Tarantini F, et al. Among authors: ricco a. Ann Hematol. 2024 Oct;103(10):4325-4327. doi: 10.1007/s00277-024-05938-y. Epub 2024 Aug 15. Ann Hematol. 2024. PMID: 39145780 No abstract available.
Long-term pharmacodynamic and clinical effects of twice- versus once-daily low-dose aspirin in essential thrombocythemia: The ARES trial.
Rocca B, Tosetto A, Petrucci G, Rossi E, Betti S, Soldati D, Iurlo A, Cattaneo D, Bucelli C, Dragani A, Di Ianni M, Ranalli P, Palandri F, Vianelli N, Beggiato E, Lanzarone G, Ruggeri M, Carli G, Elli EM, Renso R, Randi ML, Bertozzi I, Loscocco GG, Ricco A, Specchia G, Vannucchi AM, Rodeghiero F, De Stefano V, Patrono C; Aspirin Regimens in EsSential thrombocythemia (ARES) Investigators. Rocca B, et al. Among authors: ricco a. Am J Hematol. 2024 Aug;99(8):1462-1474. doi: 10.1002/ajh.27418. Epub 2024 Jun 15. Am J Hematol. 2024. PMID: 38877813 Free article. Clinical Trial.
Ropeginterferon versus Standard Therapy for Low-Risk Patients with Polycythemia Vera.
Barbui T, Vannucchi AM, De Stefano V, Carobbio A, Ghirardi A, Carioli G, Masciulli A, Rossi E, Ciceri F, Bonifacio M, Iurlo A, Palandri F, Benevolo G, Pane F, Ricco A, Carli G, Caramella M, Rapezzi D, Musolino C, Siragusa S, Rumi E, Patriarca A, Cascavilla N, Mora B, Cacciola E, Mannarelli C, Loscocco GG, Guglielmelli P, Gesullo F, Betti S, Lunghi F, Scaffidi L, Bucelli C, Vianelli N, Bellini M, Finazzi MC, Tognoni G, Rambaldi A. Barbui T, et al. Among authors: ricco a. NEJM Evid. 2023 Jun;2(6):EVIDoa2200335. doi: 10.1056/EVIDoa2200335. Epub 2023 May 15. NEJM Evid. 2023. PMID: 38320126 Clinical Trial.
156 results